The Panagora 7th Annual Digital Biomarkers in Clinical Trials Summit, held in Basel, Switzerland, was a hub of innovation,...

A pivotal Phase 3 trial (inMIND) has demonstrated the efficacy of tafasitamab in combination with lenalidomide and rituximab for...

The 7th Annual Digital Biomarkers in Clinical Trials Summit recently featured a compelling presentation by William Johnston, Digital Endpoint...

The FDA has approved Niktimvo for treating chronic graft-versus-host disease (GVHD) in adults and children weighing over 40 kg....

Tivic Health, a bioelectronic medicine company, announced its financial results for the second quarter of 2024, highlighting its commitment...

The PPD clinical research arm of Thermo Fisher Scientific has consistently been acknowledged as an industry leader in digital...

The U.S. Food and Drug Administration (FDA) has approved Livdelzi (seladelpar) for treating primary biliary cholangitis (PBC), an autoimmune...

ViroCell Biologics, a specialized CDMO in GMP viral vector manufacturing, has successfully closed an oversubscribed convertible note offering to...

Medable introduces Medable Studio, a revolutionary application that simplifies and accelerates the process of configuring, translating, and launching eClinical...

Anti-TIGIT antibodies are revolutionizing cancer treatment by targeting the immune inhibitory receptor TIGIT, expressed on T cells and NK...